US STOCK
WST Stock Analysis
US stocks · market data · technical indicators
West Pharmaceutical Services, Inc.
WSTUS stocksQuote delayed 15 min
10/26 下午01:39 updated
$392.15
-1.88-0.48%
Open
$391.60
High
$394.18
Low
$389.72
Volume
71.84萬
WST price history
+4.39%Open
375.65
Latest
392.15
High
394.03
Low
363.27
Average
376.58
Advertisement
Financial snapshot
WST - West Pharmaceutical Services, Inc.
EPS
7.81USD
Forward EPS
9.98USD
P/E
50.21x
Forward P/E
39.28x
P/B
9.23x
ROE
19.09%
ROA
11.38%
Operating margin
22.47%
Profit margin
16.98%
Revenue growth
13.80%
Earnings growth
18.10%
Dividend yield
0.27%
Financial statements
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| Revenue | $872.30M | $844.90M | $805.00M | $804.60M | $766.50M |
| Gross profit | $329.20M | $296.40M | $303.90M | $294.30M | $273.90M |
| Operating income | $191.90M | $181.10M | $175.10M | $174.50M | $158.90M |
| Net income | $154.00M | $138.80M | $132.10M | $140.00M | $131.80M |
| Basic EPS | 2.17 | 1.93 | 1.83 | 1.94 | 1.82 |
| Diluted EPS | 2.15 | 1.92 | 1.82 | 1.92 | 1.82 |
Estimates vs actuals
Next earnings
2026-10-29
EPS estimate
2.20
Revenue estimate
$826.55M
Last surprise
+13.86%
| Date | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-10-29 | 2.20 | Not reported | — |
| 2026-07-23 | 2.08 | 2.37 | +13.86% |
| 2026-04-23 | 1.68 | 2.13 | +27.07% |
| 2026-02-12 | 1.83 | 2.04 | +11.54% |
| 2025-10-23 | 1.71 | 1.96 | +14.55% |
| 2025-07-24 | 1.54 | 1.84 | +19.71% |
| 2025-04-24 | 1.26 | 1.45 | +15.28% |
| 2025-02-13 | 1.73 | 1.82 | +5.32% |
| 2024-10-24 | 1.49 | 1.85 | +23.75% |
| 2024-07-25 | 1.73 | 1.52 | -12.08% |
| 2024-04-25 | 1.29 | 1.56 | +21.17% |
| 2024-02-15 | 1.78 | 1.83 | +2.71% |
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| VANGUARD GROUP INC | 2025-12-31 | $2.6B | 0.04% |
| BlackRock Inc. | 2024-06-30 | $2.5B | 0.06% |
| STATE STREET CORP | 2026-06-30 | $1.2B | 0.04% |
| GATES FOUNDATION TRUST | 2026-06-30 | $159.6M | 0.46% |
| CITADEL ADVISORS LLC | 2026-06-30 | $126.6M | 0.01% |
| RENAISSANCE TECHNOLOGIES LLC | 2026-06-30 | $11.1M | 0.02% |
| TWO SIGMA INVESTMENTS, LP | 2026-06-30 | $6.5M | 0.00% |
| Bridgewater Associates, LP | 2026-06-30 | $3.7M | 0.02% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$416.40
Target range
$340.00 – $459.00
Implied upside
6.18%
Strong buy
3
Buy
12
Hold
0
Sell
0
Strong sell
1
Dividends
Annual yield
0.22%
Frequency
Quarterly
Recent payouts
- 2026-07-29$0.2200
- 2026-04-29$0.2200
- 2026-01-28$0.2200
- 2025-11-12$0.2200
Advertisement